17 avril 2008
This paper takes a critical look at current TB control efforts: programme strategy (DOTS), diagnostic tools and treatments, as well as research and development (R&D) needs. It hopes to spark debate about how people suffering from TB can best be helped, and especially what role MSF can play on the medical, operational and political levels.
À lire aussi
Tuberculose résistante : l’accès aux nouveaux traitements se heurte au manque d…
Communiqué de presse